BRD2 and polycystic ovary syndrome: Studies showed that melatonin treatment significantly decreased androgen levels; by contrast, FSH levels significantly increased and antimullerian hormone serum levels significantly decreased after 6 months of melatonin treatment in PCOS patients [28].